Medscape4y
Drug-eluting Stents: The Next Generation
Introduction Since their introduction, drug-eluting stents (DES) have revolutionized percutaneous treatment of coronary artery disease with rates of in-stent restenosis of between 2 and 10% [] and ...
Trial finds drug-coated balloon angioplasty less effective than second generation drug-eluting stents
did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise ...
FierceBiotech6d
Abbott posts positive, longer-term data for its dissolving Esprit BTK stent
Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...
MassDevice6d
Abbott reports sustained benefits with Esprit drug-eluting stent
Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.
Healthline5d
Understanding What Stent Thrombosis Is
You’ll usually need to continue dual antiplatelet drug therapy for a year after a drug-eluting stent placement and a month after a bare-metal stent placement. Drug-eluting stents are a newer ...
Nature4mon
Therapy Insight: diabetes and drug-eluting stents
More recently, drug-eluting stents (DESs ... The Strategic Transcatheter Evaluation of New Therapies (STENT) registry group reported results from 5,566 patients who underwent DES treatment ...
EurekAlert!13d
Orbital atherectomy prior to coronary stent implantation does not lead to better outcomes compared to conventional balloon angioplasty
Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...
Endovascular Today6d
ELEGANCE Registry Studies Drug-Eluting Device Treatment of PAD in Underrepresented Minorities and Women
The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...
TCTMD13d
TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up
TCT 15: Impact of High Lipoprotein(a) Levels on 5-Year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent in Korean Population Receive the the latest news, research ...
Business Wire13d
Elixir Medical’s DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion ...
Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced late-breaking data demonstrating significant b ...
Yahoo Finance11d
Non-Drug Eluting Device Market Analysis Report 2024: Global Size, Trends, Opportunities and Forecasts 2020-2030
Non-drug eluting devices, such as bare-metal stents, catheters, and implantable medical devices, are widely used in procedures where drug elution is not necessary, or where a more mechanical or ...
Medscape3d
Drug-eluting Stents: The Next Generation
Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...